Netherlands Reference Laboratory for Bacterial Meningitis: Bacterial meningitis in the Netherlands: annual report 2006. 2007, Amsterdam, The Netherlands: AMC/RIVM
Google Scholar
Saez-Llorens X, McCracken GH: Bacterial meningitis in children. Lancet. 2003, 361: 2139-2148. 10.1016/S0140-6736(03)13693-8.
Article
PubMed
Google Scholar
Baraff LJ, Lee SI, Schriger DL: Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J. 1993, 12: 389-394. 10.1097/00006454-199305000-00008.
Article
CAS
PubMed
Google Scholar
Grimwood K, Anderson VA, Bond L, Catroppa C, Hore RL, Keir EH, Nolan T, Roberton DM: Adverse outcomes of bacterial meningitis in school-age survivors. Pediatrics. 1995, 95: 646-656.
CAS
PubMed
Google Scholar
Koomen I, Grobbee DE, Roord JJ, Donders R, Jennekens-Schinkel A, van Furth AM: Hearing loss at school age in survivors of bacterial meningitis: assessment, incidence, and prediction. Pediatrics. 2003, 112: 1049-1053. 10.1542/peds.112.5.1049.
Article
PubMed
Google Scholar
Koomen I, Grobbee DE, Roord JJ, Jennekens-Schinkel A, van der Lei HD, Kraak MA, van Furth AM: Prediction of academic and behavioural limitations in school-age survivors of bacterial meningitis. Acta Paediatr. 2004, 93: 1378-1385. 10.1111/j.1651-2227.2004.tb02939.x.
Article
CAS
PubMed
Google Scholar
Lutsar I, Siirde T, Soopold T: Long term follow-up of Estonian children after bacterial meningitis. Pediatr Infect Dis J. 1995, 14: 624-625. 10.1097/00006454-199507000-00014.
Article
CAS
PubMed
Google Scholar
Center KJ: Prevenar vaccination: review of the global data, 2006. Vaccine. 2007, 25: 3085-3089. 10.1016/j.vaccine.2007.01.021.
Article
PubMed
Google Scholar
Dias R, Canica M: Invasive pneumococcal disease in Portugal prior to and after the introduction of pneumococcal heptavalent conjugate vaccine. FEMS Immunol Med Microbiol. 2007, 51: 35-42. 10.1111/j.1574-695X.2007.00283.x.
Article
CAS
PubMed
Google Scholar
Jacobs MR, Good CE, Bajaksouzian S, Windau AR: Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Clin Infect Dis. 2008, 47: 1388-1395. 10.1086/592972.
Article
PubMed
Google Scholar
Mera R, Miller LA, Fritsche TR, Jones RN: Serotype replacement and multiple resistance in Streptococcus pneumoniae after the introduction of the conjugate pneumococcal vaccine. Microb Drug Resist. 2008, 14: 101-107. 10.1089/mdr.2008.0782.
Article
CAS
PubMed
Google Scholar
Pletz MW, Maus U, Krug N, Welte T, Lode H: Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents. 2008
Google Scholar
Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, Zell E, Lexau CA, Thomas AR, Harrison LH, Reingold AL, et al: Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. Jama. 2006, 295: 1668-1674. 10.1001/jama.295.14.1668.
Article
CAS
PubMed
Google Scholar
Achenbach TM, McConaughy SH: Empirically Based assessment of Child and Adolescent Psychopathology. 1997, Thousand Oaks, CA: Sage
Google Scholar
Jansen AG, Rodenburg GD, van der Ende A, van Alphen L, Veenhoven RH, Spanjaard L, Sanders EA, Hak E: Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clin Infect Dis. 2009, 49: e23-29. 10.1086/600045.
Article
PubMed
Google Scholar
Altman DG, Royston P: What do we mean by validating a prognostic model?. Stat Med. 2000, 19: 453-473. 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5.
Article
CAS
PubMed
Google Scholar
Altman DG, Vergouwe Y, Royston P, Moons KG: Prognosis and prognostic research: validating a prognostic model. Bmj. 2009, 338: b605-10.1136/bmj.b605.
Article
PubMed
Google Scholar
Bleeker SE, Moll HA, Steyerberg EW, Donders AR, Derksen-Lubsen G, Grobbee DE, Moons KG: External validation is necessary in prediction research: a clinical example. J Clin Epidemiol. 2003, 56: 826-832. 10.1016/S0895-4356(03)00207-5.
Article
CAS
PubMed
Google Scholar
Toll DB, Janssen KJ, Vergouwe Y, Moons KG: Validation, updating and impact of clinical prediction rules: a review. J Clin Epidemiol. 2008, 61: 1085-1094. 10.1016/j.jclinepi.2008.04.008.
Article
CAS
PubMed
Google Scholar
Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al: Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J. 2000, 19: 187-195. 10.1097/00006454-200003000-00003.
Article
CAS
PubMed
Google Scholar
Vestrheim DF, Lovoll O, Aaberge IS, Caugant DA, Hoiby EA, Bakke H, Bergsaker MR: Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway. Vaccine. 2008, 26: 3277-3281. 10.1016/j.vaccine.2008.03.087.
Article
CAS
PubMed
Google Scholar
Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction--eight states, 1998-2005. MMWR Morb Mortal Wkly Rep. 2008, 57: 144-148.
Hammitt LL, Bruden DL, Butler JC, Baggett HC, Hurlburt DA, Reasonover A, Hennessy TW: Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis. 2006, 193: 1487-1494. 10.1086/503805.
Article
PubMed
Google Scholar